ELTX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Elicio Therapeutics Inc (ELTX) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock shows no significant positive trading signals, lacks recent news catalysts, and has weak financial performance. While technical indicators are mildly positive, the lack of strong momentum and poor financials suggest holding off on investment until more favorable conditions arise.
The stock's MACD is positive and contracting, indicating mild bullish momentum. RSI is neutral at 57.008, showing no overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading above its pivot point of 11.643. However, the price remains close to support levels, and the overall trend lacks strong upward momentum.
Bullish moving averages and positive MACD. Options sentiment is bullish with low put-call ratios.
No recent news or event-driven catalysts. Financial performance is weak, with declining net income (-46.48% YoY) and EPS (-56.83% YoY). No significant hedge fund or insider activity. Congress trading data is absent.
In Q3 2025, revenue remained at 0 with no growth. Net income dropped significantly to -$10,083,000 (-46.48% YoY), and EPS fell to -0.6 (-56.83% YoY). Gross margin is 0, reflecting no profitability.
No recent analyst ratings or price target changes are available for ELTX.
